Ellia Tootoonchian

Ellia Tootoonchian

Auto-generated profile, based on publicly available information

Ellia Tootoonchian

Data & Research, World Federation of Hemophilia, Montreal, Quebec

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2024 in Expert Review of Hematology
Verified
Journal Article
Closed access
MJM Joseph John
M Joseph John
JSJeff Stonebraker
Jeff Stonebraker
AJAikaj Jindal
Aikaj Jindal
ETEllia Tootoonchian
Ellia Tootoonchian
GPGlenn P Pierce
Glenn P Pierce
DCDonna Coffin
Donna Coffin
Prophylaxis is the recommended management strategy for all persons with hemophilia (PwH), yet its adoption is uneven worldwide. This analysis examines global disparities in hemophilia care, focusing on global prophylactic coverage and its correlation with the World Bank's world development indicators. It outlines the disproportionate consumption of clotting factors and non-factor concentrates in high-income countries compared to lower-income counterparts and the challenges of expanding prophylaxis coverage in under-resourced settings. The analysis integrates socioeconomic data with global health indicators to understand these disparities and advocates for increased distribution of treatment resources across all income levels, emphasizing the need for policy changes to improve hemophilia care worldwide. Studies addressing the prophylaxis perspectives in hemophilia were selected using PubMed and google scholar platforms (unlimited time frame). Articles were supplemented with WFH's annual surveys and guidelines, including the WFH Global Survey 2022, WFH Guidelines for the Management of Hemophilia 2020 and World Bank data. Significant disparities in hemophilia care and factor usage exist between high-income and lower-income countries. Standardized, harmonized metrics for different types of factor consumption are critical to accurately assess and compare hemophilia care on an international basis.